Abstract
The complex nature and polygenic determination of most bone disorders require new approaches to search for genes and genetic mechanisms underlying these diseases. The present article overviews powerful and promising methodologies, which have been used to study these disorders. One of the most commonly used approaches is that of candidate gene association study, which seeks to test the association between a particular genetic variant (i.e. allele) and a specific phenotypes. These candidate genes are identified a priori based on known biologic function of gene product. As a complement of the candidate gene approach, the whole-genome scan studies employ polymorphic makers throughout the human genome to search genomic regions responsible for determining a trait of interest by linkage and / or linkage disequilibrium analyses. High-throughput methods for differential gene expression profiling are another powerful approach for searching genes underlying complex traits. Depending on their design, these methods allow researchers to get a “snapshot” of either the whole genome or any part. Importantly, in contrast to the various linkage or linkage disequilibrium tests, gene expression profiling provides information about how genes contribute to a trait. These methods of gene expression analysis are a rapidly developing field of functional genomics. It has a very high potential for applications in bone field, including diagnostics, prevention, and treatment of complex bone disorders. Genes usually function via the protein level. Based on the two-dimensional polyacrylamide gel electrophoresis, mass spectrometry and the yeast two-hybrid techniques, proteomics becomes a potentially useful tool for identifying genes and gene functions underlying complex traits. Focused on protein expression profiles and protein-protein interactions, proteomics turns out to be a complement to functional genomics and one of the best ways to clarify complicated biochemical mechanisms underlying complex bone disorders. Promisingly, proteomics may be eventually applied to seeking and screening genes and drug targets for complex bone disorders.
Keywords: Bone Disorders, proteomics, protein-protein interactions
Current Genomics
Title: Systemic Approach to the Study of Complex Bone Disorders at the Whole- Genome Level
Volume: 5 Issue: 2
Author(s): Volodymyr Dvornyk, Peng Xiao, Yong- Jun Liu, Hui Shen and Hong- Wen Deng
Affiliation:
Keywords: Bone Disorders, proteomics, protein-protein interactions
Abstract: The complex nature and polygenic determination of most bone disorders require new approaches to search for genes and genetic mechanisms underlying these diseases. The present article overviews powerful and promising methodologies, which have been used to study these disorders. One of the most commonly used approaches is that of candidate gene association study, which seeks to test the association between a particular genetic variant (i.e. allele) and a specific phenotypes. These candidate genes are identified a priori based on known biologic function of gene product. As a complement of the candidate gene approach, the whole-genome scan studies employ polymorphic makers throughout the human genome to search genomic regions responsible for determining a trait of interest by linkage and / or linkage disequilibrium analyses. High-throughput methods for differential gene expression profiling are another powerful approach for searching genes underlying complex traits. Depending on their design, these methods allow researchers to get a “snapshot” of either the whole genome or any part. Importantly, in contrast to the various linkage or linkage disequilibrium tests, gene expression profiling provides information about how genes contribute to a trait. These methods of gene expression analysis are a rapidly developing field of functional genomics. It has a very high potential for applications in bone field, including diagnostics, prevention, and treatment of complex bone disorders. Genes usually function via the protein level. Based on the two-dimensional polyacrylamide gel electrophoresis, mass spectrometry and the yeast two-hybrid techniques, proteomics becomes a potentially useful tool for identifying genes and gene functions underlying complex traits. Focused on protein expression profiles and protein-protein interactions, proteomics turns out to be a complement to functional genomics and one of the best ways to clarify complicated biochemical mechanisms underlying complex bone disorders. Promisingly, proteomics may be eventually applied to seeking and screening genes and drug targets for complex bone disorders.
Export Options
About this article
Cite this article as:
Dvornyk Volodymyr, Xiao Peng, Liu Jun Yong-, Shen Hui and Deng Wen Hong-, Systemic Approach to the Study of Complex Bone Disorders at the Whole- Genome Level, Current Genomics 2004; 5 (2) . https://dx.doi.org/10.2174/1389202043489926
DOI https://dx.doi.org/10.2174/1389202043489926 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tumor Dormancy and the Angiogenic Switch: Possible Implications of Bone Marrow- Derived Cells
Current Pharmaceutical Design HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
Current Pharmaceutical Design Synthesis of Pyrophosphate-Containing Compounds that Stimulate VγVδ2 T Cells: Application to Cancer Immunotherapy
Medicinal Chemistry Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer
Current Pharmaceutical Biotechnology Bladder Cancer and Stem Cells
Current Signal Transduction Therapy The Impact of L-Carnitine and Coenzyme Q10 as Protection Against Busulfan-Oxidative Stress in the Liver of Adult Rats
The Natural Products Journal Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Current Medicinal Chemistry Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting
Current Molecular Pharmacology PET and SPECT Imaging of Tumor Biology: New Approaches Towards Oncology Drug Discovery and Development
Current Computer-Aided Drug Design Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?
Current Drug Targets Cancer/Testis Antigens Trigger Epithelial-Mesenchymal Transition and Genesis of Cancer Stem-Like Cells
Current Pharmaceutical Design Cucurbitacin IIb from Ibervillea sonorae Induces Apoptosis and Cell Cycle Arrest via STAT3 Inhibition
Anti-Cancer Agents in Medicinal Chemistry The Role of Hypoxia in Endometrial Cancer
Current Pharmaceutical Biotechnology Thyroid Hormone Levels in the Prefrontal Cortex of Post-Mortem Brains of Alzheimers Disease Patients
Current Aging Science Advent and Maturation of Regenerative Medicine
Current Stem Cell Research & Therapy Synthesis and Biological Evaluation of Scutellaria Flavone Cyclaneaminol Mannich Base Derivatives as Novel CDK1 Inhibitors
Anti-Cancer Agents in Medicinal Chemistry A Comprehensive Review on Ethnomedicinal, Pharmacological and Phytochemical Basis of Anticancer Medicinal Plants of Pakistan
Current Cancer Drug Targets Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome
Anti-Cancer Agents in Medicinal Chemistry 99mTc-labeling of Peptidomimetic Antagonist to Selectively Target αvβ3 Receptor-Positive Tumor: Comparison of PDA and EDDA as Co-Ligands
Current Radiopharmaceuticals Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Current Drug Targets